supported by the National Basic Research Program of China (Grant Nos. 2005CB522902 and 2007CB512900);the National High Technology Research and Development Program of China (Grant No. 2006AA02A410);the National Natural Science Foundation of China (Grant No. 30901256);the Beijing Natural Science Foundation (Grant No. 7102153);National Science and Technology Major Project for Infectious Diseases Control During the 11th Five-Year Plan Period (Grant Nos. 2008ZX10002-012 and 2008ZX10002-013);Peking University People’s Hospital Research Development Funds (Grant No. RDC 2009-13);Key Clinical Research Program of Ministry of Health of China
The efficacy of interferon (IFN) is limited in about 1/3 of patients with chronic hepatitis B (CHB). We used two-dimensional electrophoresis (2-DE)-based proteomic strategies to identify potential serum markers predic...